Related Experiment Video
Updated: Jan 16, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Impact of PREVENT Cardiovascular Risk Equations on Statin Eligibility by Subgroup and Risk Thresholds: A
Aileen P Wright1,2, Allison B McCoy3, Kimberly Garcia3
1Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA. aileen.p.wright.1@vumc.org.
The new PREVENT equations significantly lower atherosclerotic cardiovascular disease (ASCVD) risk scores compared to PCEs, reducing statin eligibility. Adjusting risk thresholds increases overall eligibility but impacts subgroups disproportionately.
Area of Science:
- Cardiovascular Medicine
- Public Health
- Health Services Research
Background:
- The Pooled Cohort Equations (PCEs) for atherosclerotic cardiovascular disease (ASCVD) risk assessment may be replaced by the Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) equations.
- This transition is projected to decrease statin eligibility, leading to discussions about adjusting risk thresholds for PREVENT.
- The impact of these changes on statin eligibility across diverse patient subgroups remains unclear.
Purpose of the Study:
- To evaluate how replacing PCEs with PREVENT equations affects statin eligibility in a primary care setting.
- To analyze the influence of incorporating the social deprivation index (SDI) and modifying ASCVD risk thresholds on statin eligibility.
- To examine subgroup variations in statin eligibility based on age, sex, race, and social deprivation.
Main Methods:
- A cross-sectional analysis compared 10-year ASCVD risk scores and statin eligibility using PCEs and PREVENT equations.
- Data were sourced from adult patients visiting Vanderbilt primary care clinics in 2023.
- Subgroup analyses explored variations by age, sex, race, and social deprivation, with risk thresholds for statin eligibility systematically altered.
Main Results:
- The PREVENT equations yielded significantly lower mean 10-year ASCVD risk (3.6%) compared to PCEs (7.5%) across 50,123 patients.
- For patients not on statins (n=36,430), PREVENT reduced statin eligibility by 78.2%, with greater reductions observed in women (82.6%), 40-49-year-olds (97.8%), and Black patients (81.2%).
- Lowering the threshold to 3% increased overall eligibility but widened subgroup disparities, with Black patients experiencing a relative decrease while White patients saw an increase.
Conclusions:
- Replacing PCEs with PREVENT equations substantially decreases statin eligibility at the standard 7.5% threshold in primary care.
- Adjusting the risk threshold increases overall eligibility but creates or exacerbates disparities among different demographic groups.
- The findings highlight the need for careful consideration of risk thresholds and subgroup impacts when implementing new ASCVD risk prediction tools.
More Related Videos
08:21Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Relative Risk
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration